Elevated levels of bile acids in colostrum of patients with cholestasis of pregnancy are decreased following ursodeoxycholic acid therapy

Journal of Hepatology

Volumn 29, Issue 5, 1998, Pages 743-751

  Brites, Dora ^a   Rodriguez, Cecília M P ^a,b  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^b INSTITUTO SUPERIOR DE CIÊNCIAS DA SAÚDE EGAS MONIZ   (Portugal)

Author keywords

Bile acids; Cholestasis of pregnancy; Colostrum; Serum; Ursodeoxycholic acid therapy

Indexed keywords

BILE ACID; CHOLIC ACID; URSODEOXYCHOLIC ACID;

ADULT; ARTICLE; BILE ACID BLOOD LEVEL; CLINICAL ARTICLE; COLOSTRUM; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTRAHEPATIC CHOLESTASIS; LIVER FUNCTION; MILK LEVEL; PATIENT CODING; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PRURITUS;

EID: 0032211517     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80255-9     Document Type: Article

References (60)

1. Heikkinen J, Mäentausta O, Ylöstalo P, Jänne O. Changes in serum bile acids concentrations during normal pregnancy, in patients with intrahepatic cholestasis of pregnancy and in pregnant women with itching. Br J Obstet Gynaecol. 88:1981;240-245.
2. Reyes H. The enigma of intrahepatic cholestasis of pregnancy: lessons from Chile. Hepatology. 2:1982;87-96.
3. Bacq Y, Myara A, Brechot M-C, Hamon C, Studer E, Trivin F, et al. Serum conjugated bile acids profile during intrahepatic cholestasis of pregnancy. J Hepatol. 22:1995;66-70.
4. Brites D, Rodrigues CMP, Oliveira N, Cardoso Mc, Graça LM. Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy. J Hepatol. 28:1998;91-98.
5. Brites D, Rodrigues CMP, Cardoso MC, Graça LM. Unusual case of severe cholestasis of pregnancy with early onset, improved by ursodeoxycholic acid administration. Eur J Obstet Gynecol Reprod Biol. 76:1988;165-168.
6. Van Dyke RW. The liver in pregnancy. Zakim D, Boyer TD. Hepatology. 2:1990;1438-1459 WB Saunders, Philadelphia. A Textbook of Liver Disease.
7. Reyes H, Gonzales MC, Ribalta J, Aburto H, Matuss C, Schramm G, et al. Prevalence of intrahepatic cholestasis of pregnancy in Chile. Ann Intern Med. 88:1978;487-493.
8. Fisk NM, Storey GNB. Fetal outcome in obstetric cholestasis. Br J Obstet Cynaecol. 95:1988;1137-1143.
9. Reyes H, Radrigán ME, Gonzales MC, Latorre R, Ribalta J, Segovia N, et al. Steatorrhea in patients with intrahepatic cholestasis of pregnancy. Gastroenterology. 93:1987;584-590.
10. Sepulveda WH, Gonzalez C, Cruz MA, Rudolph MI. Vasoconstrictive effect of bile acids on isolated human placental chorionic veins. Eur J Obstet Gynecol Reprod Biol. 42:1991;211-215.
11. Serrano MA, Brites D, Larena MG, Monte MJ, Bravo MP, Oliveira N, et al. Beneficial effect of ursodeoxycholic acid on alterations induced by cholestatis of pregnancy in bile acid transport across the human placenta. J Hepatol. 28:1998;829-839.
12. Heikkinen J, Mäentausta O, Tuimala R, Ylöstalo P, Jänne O. Amniotic fluid bile acids in normal and patholologic pregnancy. Obstet Gynecol. 56:1980;60-64.
13. Heikkinen J, Ylöstalo P, Mäentausta O, Jänne O. Bile acids in maternal serum, umbilical cord serum and amniotic fluid of healthy women, women with pruritus and patienst with intraheptaic cholestasis of pregnancy. J Obstet Gynaecol. 4:1983;17-20.
14. Palma J, Reyes H, Ribalta J, Iglesias J, Gonzales Mc, Hernandez I, et al. Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy. Hepatology. 15:1992;1043-1047.
15. Mazzella G, Rizzo N, Salzetta A, Iamperi R, Bovicelli L, Roda E. Management of intrahepatic cholestasis in pregnancy. Lancet. 338:1991;1594-1595.
16. Floreani A, Paternoster D, Grella v, Sacco S, Gangemi M, Chiaramonte M. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy. Br J Obstet Gynaecol. 101:1994;64-65.
17. Davies MH, da Silva RCMA, Jones SR, Weaver JB, Elias E. Fetal mortality associated with cholestasis of pregnancy and the potential benefit of therapy with ursodeoxycholic acid. Gut. 37:1995;580-584.
18. Balistreri WF, Heubi JE, Suchy FJ. Immaturity of the enterohepatic circulation in early life: factors predisposing to "physiology" maldigstion and cholestasis. J Pediatr Gastroenterol Nutr. 2:1983;346-354.
19. Lester R. Physiologic cholestasis. Gastroenterology. 78:1980;864-865.
20. De Belle RC, Vaupshas V, Vitullo BB, Haber LR, Shaffer E, Mackie GG, et al. Intestinal absorption of bile salts: immature development in the neonate. J Pediatr. 94:1979;472-476.
21. Suchy FJ, Balistreri WF, Heubi HE, Searcy JE, Levin RS. Physiologic cholestasis: elevation of the primary serum bile acid concentrations in normal infants. Gastroenterology. 80:1981;1037-1041.
22. Mashige F, Imai K, Osuga T. A simple and sensitive assay of bile acids. Clin Chim Acta. 70:1976;79-86.
23. Brites D, Silva R. Doseamento enzimático dos ácidos biliares. Optimização da reacção e valores normais. Rev Port Farm. 36:1985;8-14.
24. Feldmann D, Fenech C, Cuer JF. Evaluation of a sample preparation procedure for bile acids in serum and bile. Clin Chem. 29:1983;1694.
25. Labbé D, Gerhard M-F, Myara A, Vercambre C, Trivin F. High-performance liquid chromatographic determination of tauro- and glyco-conjugated bile acids in human serum. J Chromatogr. 490:1989;275-284.
26. Beke R, De Weerdt GA, Parijs J, Huybrechts W, Barbier F. Separation of conjugated and unconjugated bile acids by thin layer chromatography. Clin Chim Acta. 70:1976;197-199.
27. Goswami SK, Frey CF. Thin-layer chromatographic method for the separation of conjugated deoxycholic acid from conjugated chenodeoxycholic acid. J Chromatogr. 145:1978;147-150.
28. Correia LE, Brites D. Separação, identificação e quantificação dos diferentes ácidos biliares no soro. Rev Port Farm. 36:1985;30-35.
29. Rodrigues CMP, Setchell KDR. Performance characteristics of reversed-phase bonded silica cartridges for serum bile acid extraction. Biomed Chromatogr. 10:1996;1-5.
30. Hirano Y, Miyazaki H, Higashidate S, Nakayama F. Analysis of 3-sulfated and nonsulfated bile acids by one-step hydrolysis and high performance liquid chromatography. J Lipid Res. 28:1987;1524-1529.
31. Nair PP, Garcia CC. A modified gas-liquid chromatographic procedure for the rapid determination of bile acids in biological fluids. Anal Biochem. 29:1969;164-166.
32. B Almé, Bremmelgaard A, Sjövall J, Thomassen P. Analysis of metabolic profiles of bile acids in urine using a lipophilic anion exchanger and computerized gas-liquid chromatography-mass spectrometry. J Lipid Res. 18:1977;339-362.
33. Fales HM, Jaouni JM, Babashak JF. Simple device for preparing ethereal diazomethane without resorting to co-distillation. Anal Chem. 45:1973;2302-2303.
34. Blau K, King GS. Hanbook of Derivatives for Chromatography. 1978;Heyden & Son, London.
35. Axelson M, Sjövall J. Separation and computerized gas chromatography-mass spectrometry of uncojungated neutral steroids in plasma. J Steroid Biochem. 5:1974;733-738.
36. Setchell KDR. Liquid-solid extraction, lipophilic gel chromatography and capillary column gas chromatography in the analysis of bile acids from biological samples. Barbara L, Dowling RH, Hofmann AF, Roda E. Bile Acids in Gastroenterology. 1982;1-18 MTP Press, Lancaster.
37. Johnston WG, Baskett TF. Obstetric cholestasis: a 14 year review. Am J Obstet Gynecol. 133:1979;299-301.
38. Sjövall K, Sjövall J. Serum bile acids levels in pregnacy with pruritus (bile acids and steroids 58). Clin Chim Acta. 13:1966;207-211.
39. Meng L-J, Reyes H, Axelson M, Palma J, Hernandez I, Ribalta J, et al. Progesterone Metabolites and bile acids in serum of patients with intrahepatic cholestasis of pregnancy: effect of ursodeoxycholic acid therapy. Hepatology. 26:1997;1573-1579.
40. Meng L-J, Reyes H, Palma J, Hernandez I, Ribalta J, Sjövall J. Effects of ursodeoxycholic acid on conjugated bile acids and progresterone metabolites in serum and urine of patients with intrahepatic cholestasis of pregnancy. J Hepatol. 27:1997;1029-1040.
41. Palma J, Reyes H, Ribalta J, Hernandez I, Sandoval L, Almuna R, et al. Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized, double-blind study controlled with placebo. J Hepatol. 27:1997;1022-1028.
42. Reyes H, Simon FR. Intrahepatic cholestasis of pregnancy: an estrogen-related disease. Semin Liver Dis. 13:1993;289-301.
43. Berg B, Helm G, Retersohn L, Tryding N. Cholestasis of pregnancy. Clinical and laboratory studies. Acta Obstet Gynaecol Scand. 65:1986;107-113.
44. Reyes H. The spectrum of liver and gastrointestinal disease seen in cholestasis of pregnancy. Riley CA, Abell TL. Gastroenterology Clinics of North America. Gastrointestinal and Liver Problems in Pregnancy. 1992;905-921 WB Saunders, Philadelphia.
45. Alsulyman OM, Ouzounian JG, Ames-Castro M, Goodwin TM. Intrahepatic cholestasis of pregnancy: perinatal outcome associated with expectant management. Am J Obstet Gynecol. 175:1996;957-960.
46. Brites D, Oliveira N, van-Zeller H, Rodrigues CMP, Brito A. Correction of fetal cord serum bile acid profile by maternal ursodeoxycholic acid therapy in cholestasis of pregnancy [abstract]. J Hepatol. 26:1997;163. (suppl).
47. ppl.
48. Celigloglu M, Celiker S, Guven H, Tuncok Y, Demir N, Erten O. Gertamicin excretion and uptake from breast milk by nursing infants. Obstet Gynecol. 1994;263-265.
49. Bourget P, Pons J-C, Delouis C, Fermont L, Frydman R. Flecainide distribution, transplacental passage, and accumulation in the amniotic fluid during the third trimester of pregnancy. Ann Pharmacother. 28:1994;1031-1034.
50. Wojnar-Horton RE, Hackett LP, Yapp P, LJ Dusci, Paech M, Ilett KF. Distribution and excretion of sumatriptan in human milk. Br J Clin Pharmacol. 41:1996;217-221.
51. Dickson PH, Lind A, Studts P, Nipper HC, Makoid M, Therkildsen D. The routine analysis of breast milk for drugs of abuse in a clinical toxicology laboratory. J Forensic Sci. 39:1994;207-214.
52. Kauffman RE. Therapeutic challenges. Prenatal and paediatric safety considerations. 5:1990;65-70. Drug Saf.
53. Forsyth JS, Ross PE, Bouchier IAD. Bile salts in breast milk. Eur J Peditr. 140:1983;126-127.
54. Forsyth JS, Donnet L, Ross PE. A study of the relationship between bile salts, bile salt-stimulated lipase, and free fatty acids in breast milk: normal infants and those with breast milk jaundice. J Pediatr Gastroenterol Nutr. 11:1990;205-210.
55. Taddio A, Ito S, Koren G. Excretion of fluoxetine and its metabolite, norfluoxitine, in human breast milk. J Clin Pharmacol. 36:1996;42-47.
56. Jain S, Bijlani RL. The significance of some significant features of breast milk. Indian J Physiol Pharmacol. 33:1989;118-128.
57. Fulton IC, Douglas JG, Hutchon DJR, Beckett GJ. Is normal pregnancy cholestatic? Clin Chim Acta. 130:1983;171-176.
58. Carter J. Serum bile acids in normal pregnancy. Br J Obstet Gynaecol. 98:1991;540-543.
59. Läatikainen T, Lehtonen P, Heeso A. Biliary bile acids in uncomplicated pregnancy and in cholestasis of pregnancy. Clin Chim Acta. 85:1978;145-150.
60. Lammi-Keefe CJ, Jensen RG. Characteristics and benefits of bile salts-stimulated lipase in human milk. Nutr Rev. 42:1984;372-373.